MAP2K7 and melanoma: Recently, alternative experimental approaches have been identified to inhibit NRAS-mutated melanomas: particularly, it was shown in experimental models of NRAS-mutated melanomas that the combined inhibition of MEK and CDK4 induced apoptosis and inhibited tumor cell proliferation [59].